Okan Bakıner

885 total citations
31 papers, 293 citations indexed

About

Okan Bakıner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Okan Bakıner has authored 31 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Okan Bakıner's work include Diabetes Treatment and Management (6 papers), Ophthalmology and Eye Disorders (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Okan Bakıner is often cited by papers focused on Diabetes Treatment and Management (6 papers), Ophthalmology and Eye Disorders (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Okan Bakıner collaborates with scholars based in Türkiye, Czechia and France. Okan Bakıner's co-authors include Emre Bozkırlı, Melek Eda Ertörer, Neslihan Başçıl Tütüncü, Nilgün Güvener Demirağ, Selçuk Sızmaz, İlknur Kozanoğlu, Nurzen Sezgin, İnan Anaforoğlu, Akatlı Kürşad Özşahin and Tevfik Demir and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care and Clinical Endocrinology.

In The Last Decade

Okan Bakıner

29 papers receiving 283 citations

Peers

Okan Bakıner

EDM

PHYSI

SURGE

EPIDE

CCM

Faruk Kutlutürk Türkiye

Okcan Basat Türkiye

Paola Galoppi Italy

Dongwon Yi South Korea

Fernando Bugatto Spain

Gemma Rodríguez-Carnero Spain

Ruifei Yang China

Adnan Gökçel Türkiye

Vincenzo Salpietro Italy

Premlata K Varthakavi India

Faruk Kutlutürk Türkiye

Okan Bakıner

116 ×1.0

EDM

42 ×0.6

PHYSI

26 ×0.6

SURGE

31 ×0.7

EPIDE

37 ×0.9

CCM

Citations per year, relative to Okan Bakıner Okan Bakıner (= 1×) peers Faruk Kutlutürk

Countries citing papers authored by Okan Bakıner

Since Specialization

Citations

This map shows the geographic impact of Okan Bakıner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Okan Bakıner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Okan Bakıner more than expected).

Fields of papers citing papers by Okan Bakıner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Okan Bakıner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Okan Bakıner. The network helps show where Okan Bakıner may publish in the future.

Co-authorship network of co-authors of Okan Bakıner

This figure shows the co-authorship network connecting the top 25 collaborators of Okan Bakıner. A scholar is included among the top collaborators of Okan Bakıner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Okan Bakıner. Okan Bakıner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haluzı́k, Martin, et al.. (2025). Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli‐ SWITCH study. Diabetes Obesity and Metabolism. 27(5). 2730–2739. 2 indexed citations

Bakıner, Okan, et al.. (2024). Tip 2 Diyabetli Hastalarda SGLT2 İnhibitörlerinin Hematolojik Parametreler Üzerindeki Etkileri: Retrospektif Bir Çalışma. DergiPark (Istanbul University). 8(2). 154–162.

Şahin, İbrahim, et al.. (2024). Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review. Diabetes Therapy. 15(8). 1687–1716. 14 indexed citations

Bakıner, Okan, et al.. (2020). Effect of type 2 diabetes mellitus on efficacy and safety of therapeutic apheresis for severe hypertriglyceridemia. Therapeutic Apheresis and Dialysis. 25(5). 681–686. 1 indexed citations

Bakıner, Okan, et al.. (2020). Glucagon-Like Polypeptide-1 and Brain. Endocrinology research and practice.. 24(4). 343–355. 1 indexed citations

Bakıner, Okan, et al.. (2017). Mean platelet volume in Graves’ disease: A sign of hypermetabolism rather than autoimmunity?. Pakistan Journal of Medical Sciences. 33(4). 871–875. 7 indexed citations

Bakıner, Okan, et al.. (2016). Postprandial Hypoglycemia: An Unusual Presentation for Insulinoma. SHILAP Revista de lepidopterología. 20(1). 22–25. 1 indexed citations

Ertörer, Melek Eda, et al.. (2015). Low Prevalence of Periodontitis in Acromegaly: Growth Hormone May Exert a Protective Effect. SHILAP Revista de lepidopterología. 19(2). 42–48. 4 indexed citations

Bozkırlı, Emre, Okan Bakıner, Melek Eda Ertörer, et al.. (2015). Insulin Resistance in Non-Obese Polycystic Ovary Syndrome Subjects and Relation with Family History of Diabetes Mellitus. SHILAP Revista de lepidopterología. 19(2). 55–59. 6 indexed citations

10.

Bakıner, Okan, et al.. (2015). Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes. Medical Principles and Practice. 25(1). 61–66. 11 indexed citations

11.

Bozkırlı, Emre, et al.. (2014). Serum Immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy. Clinical Endocrinology. 83(6). 962–967. 27 indexed citations

12.

Bakıner, Okan, et al.. (2013). Assessment of prenatal and perinatal characteristics of pregnants with gestationel diabetes mellitus who have postnatal glucose abnormalities. DergiPark (Istanbul University).

13.

Bakıner, Okan, Emre Bozkırlı, Derun Taner Ertuğrul, Nurzen Sezgin, & Melek Eda Ertörer. (2013). Plasma fetuin-A levels are reduced in patients with hypothyroidism. European Journal of Endocrinology. 170(3). 411–418. 16 indexed citations

14.

Bozkırlı, Emre, et al.. (2013). A Case of Inoperable Malignant Insulinoma with Resistant Hypoglycemia Who Experienced the Most Significant Clinical Improvement with Everolimus. SHILAP Revista de lepidopterología. 2013. 1–6. 7 indexed citations

15.

Bozkırlı, Emre, et al.. (2013). Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline. SHILAP Revista de lepidopterología. 2013. 1–4. 1 indexed citations

16.

Sızmaz, Selçuk, et al.. (2013). Assessment of Tear Meniscus with Optical Coherence Tomography in Thyroid-Associated Ophtalmopathy. Current Eye Research. 39(4). 323–328. 13 indexed citations

17.

Anaforoğlu, İnan, Melek Eda Ertörer, İlknur Kozanoğlu, et al.. (2010). Macroprolactinemia, like hyperprolactinemia, may promote platelet activation. Endocrine. 37(2). 294–300. 10 indexed citations

18.

Bakıner, Okan, Melek Eda Ertörer, Emre Bozkırlı, Neslihan Başçıl Tütüncü, & Nilgün Güvener Demirağ. (2008). Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetologica. 46(1). 63–65. 41 indexed citations

19.

Bakıner, Okan, et al.. (2008). Subclinical Hypothyroidism Is Characterized by Increased QT Interval Dispersion among Women. Medical Principles and Practice. 17(5). 390–394. 34 indexed citations

20.

Reyhan, Mehmet, Gülşah Şeydaoğlu, Okan Bakıner, et al.. (2007). 99mTc(V)-DMSA SPECT for the assessment of disease activity in Graves' ophthalmopathy. Nuclear Medicine Communications. 28(10). 775–781. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact